| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $103.23M | $98.05M | $99.22M | $119.49M | $91.67M | $32.39M |
| R&D | $81.98M | $80.05M | $83.22M | $71.25M | $61.12M | – |
| SG&A | $21.25M | $18.01M | $16.01M | $15.26M | $13.30M | – |
| Operating Income | -$103.23M | -$98.05M | -$99.22M | -$119.49M | -$91.67M | – |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – | – |
| Net Income | -$97.17M | -$100.51M | -$93.61M | -$120.41M | -$92.94M | -$34.53M |
| EPS (basic) | -0.6200 | -1.0000 | -2.1100 | -3.7800 | -3.9300 | -1.6300 |
| EPS (diluted) | -0.6200 | -1.0000 | -2.1100 | -3.7800 | -3.9300 | -1.6300 |
| Shares (diluted) | $155.69M | $100.17M | $44.32M | $31.82M | $23.65M | – |